Clinical Trials Logo

Clinical Trial Summary

This study will examine the clinical effectiveness of Tafamidis in patients with Mixed Phenotype Transthyretin Amyloidosis using data that already exist in patients' medical records


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06393465
Study type Observational
Source Pfizer
Contact Pfizer CT.gov Call Center
Phone 1-800-718-1021
Email ClinicalTrials.gov_Inquiries@pfizer.com
Status Recruiting
Phase
Start date May 19, 2024
Completion date June 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT03842163 - Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown Etiology